Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Using natural language processing and machine learning to identify breast cancer local recurrence.

Zeng Z, Espino S, Roy A, Li X, Khan SA, Clare SE, Jiang X, Neapolitan R, Luo Y.

BMC Bioinformatics. 2018 Dec 28;19(Suppl 17):498. doi: 10.1186/s12859-018-2466-x.

2.

Mechanism of Telapristone Acetate (CDB4124) on Progesterone Receptor Action in Breast Cancer Cells.

Davaadelger B, Murphy AR, Clare SE, Lee O, Khan SA, Kim JJ.

Endocrinology. 2018 Oct 1;159(10):3581-3595. doi: 10.1210/en.2018-00559.

PMID:
30203004
3.

Pixelated spatial gene expression analysis from tissue.

Ganguli A, Ornob A, Spegazzini N, Liu Y, Damhorst G, Ghonge T, Thornton B, Konopka CJ, Dobrucki W, Clare SE, Bhargava R, Smith AM, Kosari F, Bashir R.

Nat Commun. 2018 Jan 15;9(1):202. doi: 10.1038/s41467-017-02623-9.

4.

Near-infrared remotely triggered drug-release strategies for cancer treatment.

Goodman AM, Neumann O, Nørregaard K, Henderson L, Choi MR, Clare SE, Halas NJ.

Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12419-12424. doi: 10.1073/pnas.1713137114. Epub 2017 Nov 6.

5.

"Big Data" for Breast Cancer: Where to look and what you will find.

Clare SE, Shaw PL.

NPJ Breast Cancer. 2016;2. pii: 16031. doi: 10.1038/npjbcancer.2016.31. Epub 2016 Nov 2.

6.

Motivations for contralateral prophylactic mastectomy as a function of socioeconomic status.

Baptiste DF, MacGeorge EL, Venetis MK, Mouton A, Friley LB, Pastor R, Hatten K, Lagoo J, Clare SE, Bowling MW.

BMC Womens Health. 2017 Feb 1;17(1):10. doi: 10.1186/s12905-017-0366-2.

7.

Understanding Resonant Light-Triggered DNA Release from Plasmonic Nanoparticles.

Goodman AM, Hogan NJ, Gottheim S, Li C, Clare SE, Halas NJ.

ACS Nano. 2017 Jan 24;11(1):171-179. doi: 10.1021/acsnano.6b06510. Epub 2016 Nov 30.

PMID:
28114757
8.

Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast.

Bodelon C, Oh H, Chatterjee N, Garcia-Closas M, Palakal M, Sherman ME, Pfeiffer RM, Geller B, Vacek P, Weaver DL, Chicoine R, Papathomas D, Xiang J, Patel DA, Khodr ZG, Linville L, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AMV, He C, Chanock SJ, Gierach GL, Figueroa JD.

Int J Cancer. 2017 Feb 15;140(4):825-832. doi: 10.1002/ijc.30512. Epub 2016 Nov 18.

9.

Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.

Venetis MK, MacGeorge EL, Baptiste DF, Mouton A, Friley LB, Pastor R, Hatten K, Lagoo J, Bowling MW, Clare SE.

Am J Clin Oncol. 2018 Jun;41(6):519-525. doi: 10.1097/COC.0000000000000321.

10.

Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue.

Oh H, Bodelon C, Palakal M, Chatterjee N, Sherman ME, Linville L, Geller BM, Vacek PM, Weaver DL, Chicoine RE, Papathomas D, Patel DA, Xiang J, Clare SE, Visscher DW, Mies C, Hewitt SM, Brinton LA, Storniolo AM, He C, Garcia-Closas M, Chanock SJ, Gierach GL, Figueroa JD.

Breast Cancer Res Treat. 2016 Jul;158(2):341-50. doi: 10.1007/s10549-016-3859-z. Epub 2016 Jun 24.

11.

Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes.

Clare SE, Gupta A, Choi M, Ranjan M, Lee O, Wang J, Ivancic DZ, Kim JJ, Khan SA.

BMC Cancer. 2016 May 23;16:326. doi: 10.1186/s12885-016-2355-5.

12.

Circulating sex hormones and terminal duct lobular unit involution of the normal breast.

Khodr ZG, Sherman ME, Pfeiffer RM, Gierach GL, Brinton LA, Falk RT, Patel DA, Linville LM, Papathomas D, Clare SE, Visscher DW, Mies C, Hewitt SM, Storniolo AM, Rosebrock A, Caban JJ, Figueroa JD.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2765-73. doi: 10.1158/1055-9965.EPI-14-0667.

13.

Motivations, concerns, and experiences of women who donate normal breast tissue.

Doherty EF, MacGeorge EL, Gillig T, Clare SE.

Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):105-10. doi: 10.1158/1055-9965.EPI-14-0941. Epub 2014 Oct 8.

14.

Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.

Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME.

J Natl Cancer Inst. 2014 Oct 1;106(10). pii: dju286. doi: 10.1093/jnci/dju286. Print 2014 Oct.

15.

Phenotypic plasticity in normal breast derived epithelial cells.

Sauder CA, Koziel JE, Choi M, Fox MJ, Grimes BR, Badve S, Blosser RJ, Radovich M, Lam CC, Vaughan MB, Herbert BS, Clare SE.

BMC Cell Biol. 2014 Jun 10;15:20. doi: 10.1186/1471-2121-15-20.

16.

Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.

Pardo I, Lillemoe HA, Blosser RJ, Choi M, Sauder CA, Doxey DK, Mathieson T, Hancock BA, Baptiste D, Atale R, Hickenbotham M, Zhu J, Glasscock J, Storniolo AM, Zheng F, Doerge RW, Liu Y, Badve S, Radovich M, Clare SE; Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center.

Breast Cancer Res. 2014 Mar 17;16(2):R26. doi: 10.1186/bcr3627.

17.

Characterizing the heterogeneity of triple-negative breast cancers using microdissected normal ductal epithelium and RNA-sequencing.

Radovich M, Clare SE, Atale R, Pardo I, Hancock BA, Solzak JP, Kassem N, Mathieson T, Storniolo AM, Rufenbarger C, Lillemoe HA, Blosser RJ, Choi MR, Sauder CA, Doxey D, Henry JE, Hilligoss EE, Sakarya O, Hyland FC, Hickenbotham M, Zhu J, Glasscock J, Badve S, Ivan M, Liu Y, Sledge GW, Schneider BP.

Breast Cancer Res Treat. 2014 Jan;143(1):57-68. doi: 10.1007/s10549-013-2780-y. Epub 2013 Nov 29.

18.

Potential roles of microRNAs in regulating long intergenic noncoding RNAs.

Juan L, Wang G, Radovich M, Schneider BP, Clare SE, Wang Y, Liu Y.

BMC Med Genomics. 2013;6 Suppl 1:S7. doi: 10.1186/1755-8794-6-S1-S7. Epub 2013 Jan 23.

19.

Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse.

Choi MR, Bardhan R, Stanton-Maxey KJ, Badve S, Nakshatri H, Stantz KM, Cao N, Halas NJ, Clare SE.

Cancer Nanotechnol. 2012 Dec;3(1-6):47-54. Epub 2012 Jul 20.

20.

Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.

Wei S, Liu L, Zhang J, Bowers J, Gowda GA, Seeger H, Fehm T, Neubauer HJ, Vogel U, Clare SE, Raftery D.

Mol Oncol. 2013 Jun;7(3):297-307. doi: 10.1016/j.molonc.2012.10.003. Epub 2012 Oct 25.

21.

The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast.

Sherman ME, Figueroa JD, Henry JE, Clare SE, Rufenbarger C, Storniolo AM.

Cancer Prev Res (Phila). 2012 Apr;5(4):528-35. doi: 10.1158/1940-6207.CAPR-11-0234. Epub 2012 Feb 17.

22.

Compliance differences between patients with breast cancer in university and county hospitals.

Komenaka IK, Pennington RE Jr, Schneider BP, Hsu CH, Norton LE, Clare SE, Zork NM, Goulet RJ Jr.

Clin Breast Cancer. 2010 Oct 1;10(5):385-91. doi: 10.3816/CBC.2010.n.051.

PMID:
20920983
23.

Race and ethnicity and breast cancer outcomes in an underinsured population.

Komenaka IK, Martinez ME, Pennington RE Jr, Hsu CH, Clare SE, Thompson PA, Murphy C, Zork NM, Goulet RJ Jr.

J Natl Cancer Inst. 2010 Aug 4;102(15):1178-87. doi: 10.1093/jnci/djq215. Epub 2010 Jun 23.

PMID:
20574040
24.

Nanoshell-enabled photothermal cancer therapy: impending clinical impact.

Lal S, Clare SE, Halas NJ.

Acc Chem Res. 2008 Dec;41(12):1842-51. doi: 10.1021/ar800150g.

PMID:
19053240
25.

Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.

Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.

Breast Cancer Res. 2008;10(5):R85. doi: 10.1186/bcr2155. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401.

26.

The effect of dedicated breast surgeons on the short-term outcomes in breast cancer.

Zork NM, Komenaka IK, Pennington RE Jr, Bowling MW, Norton LE, Clare SE, Goulet RJ Jr.

Ann Surg. 2008 Aug;248(2):280-5. doi: 10.1097/SLA.0b013e3181784647.

PMID:
18650639
27.

A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors.

Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE.

Nano Lett. 2007 Dec;7(12):3759-65. Epub 2007 Nov 3.

PMID:
17979310
28.

Breast cancer surgery and angiogenesis: stem cell cycle may explain heterogeneity of recurrence.

Clare SE.

Int J Surg. 2005;3(4):286-7. Epub 2005 Dec 12. No abstract available.

29.

A technique to prevent recurrence of lactiferous duct fistula.

Komenaka IK, Pennington RE Jr, Bowling MW, Clare SE, Goulet RJ Jr.

J Am Coll Surg. 2006 Aug;203(2):253-6. Epub 2006 May 30. No abstract available.

PMID:
16864039
30.

NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H.

Oncogene. 2007 Feb 1;26(5):711-24. Epub 2006 Jul 24.

PMID:
16862183
31.

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

Schuetz CS, Bonin M, Clare SE, Nieselt K, Sotlar K, Walter M, Fehm T, Solomayer E, Riess O, Wallwiener D, Kurek R, Neubauer HJ.

Cancer Res. 2006 May 15;66(10):5278-86.

32.

Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.

Neubauer H, Clare SE, Kurek R, Fehm T, Wallwiener D, Sotlar K, Nordheim A, Wozny W, Schwall GP, Poznanović S, Sastri C, Hunzinger C, Stegmann W, Schrattenholz A, Cahill MA.

Electrophoresis. 2006 May;27(9):1840-52.

PMID:
16645950
33.

Her-2/neu expression in breast cancer--A comparison of different diagnostic methods.

Benöhr P, Henkel V, Speer R, Vogel U, Sotlar K, Aydeniz B, Reiser A, Neubauer H, Tabiti K, Wallwiener D, Clare SE, Kurek R.

Anticancer Res. 2005 May-Jun;25(3B):1895-900.

34.

Impact of genetic background on nephropathy in diabetic mice.

Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM.

Am J Physiol Renal Physiol. 2006 Jan;290(1):F214-22. Epub 2005 Aug 23.

35.

Development of a delivery system for the continuous endogenous release of an anti-idiotypic antibody against ovarian carcinoma.

Hann E, Reinartz S, Clare SE, Passow S, Kissel T, Wagner U.

Hybridoma (Larchmt). 2005 Jun;24(3):133-40.

PMID:
15943560
36.

MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Ouatas T, Clare SE, Hartsough MT, De La Rosa A, Steeg PS.

Clin Exp Metastasis. 2002;19(1):35-42.

PMID:
11918081
37.

Characterization of the H1t promoter: role of conserved histone 1 AC and TG elements and dominance of the cap-proximal silencer.

Horvath GC, Clare SE, Kistler MK, Kistler WS.

Biol Reprod. 2001 Oct;65(4):1074-81.

PMID:
11566728
38.

Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.

Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS.

Cancer Res. 2001 Mar 1;61(5):2320-7.

39.
40.

The testis-specific histone H1t gene is strongly repressed by a G/C-rich region just downstream of the TATA Box.

Clare SE, Fantz DA, Kistler WS, Kistler MK.

J Biol Chem. 1997 Dec 26;272(52):33028-36.

41.

Prognostic significance of occult lymph node metastases in node-negative breast cancer.

Clare SE, Sener SF, Wilkens W, Goldschmidt R, Merkel D, Winchester DJ.

Ann Surg Oncol. 1997 Sep;4(6):447-51.

PMID:
9309332
42.

Characterization of the promoter region of the rat testis-specific histone H1t gene.

Clare SE, Hatfield WR, Fantz DA, Kistler WS, Kistler MK.

Biol Reprod. 1997 Jan;56(1):73-82.

PMID:
9002635
43.

Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

Steeg PS, Clare SE, Lawrence JA, Zhou Q.

Am J Pathol. 1996 Sep;149(3):733-8. Review. No abstract available.

44.

Stereochemical assignment of chiral phosphotriester analogues with Alu I sites.

Labeots LA, Clare SE, Ashley GW, Letsinger RL.

J Biomol Struct Dyn. 1996 Aug;14(1):111-6.

PMID:
8877567
45.

Structural specificities in acylation of hemoglobin and sickle hemoglobin by diaspirins.

Wood LE, Haney DN, Patel JR, Clare SE, Shi GY, King LC, Klotz IM.

J Biol Chem. 1981 Jul 10;256(13):7046-52.

Supplemental Content

Loading ...
Support Center